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Summary: The study of expression Quantitative Trait Loci (eQTL) is an important problem in genomics and biomedicine.
While detection (testing) of eQTL associations has been widely studied, less work has been devoted to the estimation of
eQTL effect size. To reduce false positives, detection methods frequently rely on linear modeling of rank-based normalized
or log-transformed gene expression data. Unfortunately, these approaches do not correspond to the simplest model of eQTL
action, and thus yield estimates of eQTL association that can be uninterpretable and inaccurate. In this paper we propose
a new, log-of -linear model for eQTL action, termed ACME, that captures allelic contributions to cis-acting eQTLs in an
additive fashion, yielding effect size estimates that correspond to a biologically coherent model of cis-eQTLs. We describe a
non-linear least-squares algorithm to fit the model by maximum likelihood, and obtain corresponding p-values. We perform
careful investigation of the model using a combination of simulated data and data from the Genotype Tissue Expression
(GTEx) project. Our results reveal little evidence for dominance effects, a parsimonious result that accords with a simple
biological model for allele-specific expression and supports use of the ACME model. We show that Type-I error is well-
controlled under our approach in a realistic setting, so that rank-based normalizations are unnecessary. Furthermore, we show
that such normalizations can be detrimental to power and estimation accuracy under the proposed model. We then provide
summaries of ACME effect sizes for whole-genome cis-eQTLs in the GTEx data.
Key words: eQTL analyses; eQTL effect size, nonlinear regression; multiple testing.
1. Introduction
An expression Quantitative Trait Locus (eQTL) is a genetic
polymorphism (typically a single-nucleotide polymorphism,
abbreviated by SNP) that is associated with transcriptional
expression levels in a particular tissue. The statistical analysis
of eQTLs has become increasingly important in understand-
ing molecular mechanisms connecting genetic variation to
complex traits and disease (Morley et al. (2004); Gilad et al.
(2008); Grundberg et al. (2012); Westra et al. (2013)). For
example, eQTL studies can be used to plausibly link disease
phenotypes analyzed in Genome-Wide Association Studies
(GWAS) to gene expression, with recent work focusing on
variation across tissues (Gamazon et al., 2015; Ardlie et al.,
2015). Although the underlying biology is complex, a funda-
mental step in many analyses is to compare the genotypes of
a large number of SNPs to the expression levels of all genes,
which presents challenges in computation and multiple testing
(Wright et al., 2012).
Statistical analyses of eQTLs have often been based on
standard linear regression (Shabalin, 2012), with a focus
on testing and detection. A key step, commonly considered
necessary to avoid false positives, has been to normalize
and transform the expression data prior to analysis (Beasley
et al., 2009). Often normalization removes the scale of the
expression data, and with it, a natural measure of effect size
due to genotype. As a consequence, eQTL effect size has
often been described in terms of regression partial R2 be-
tween genotype and transformed expression (see for example
Stranger et al. (2007)). However, the R2 statistic can be highly
sensitive to transformations of the response, and is difficult
to interpret biologically. An appropriate eQTL model should
reflect a coherent model of allelic contributions to expression,
and provide a null hypothesis to test for dominance (Powell
et al., 2013). Furthermore, a biologically appropriate effect-
size model will improve the accuracy of hypothesis tests (as we
show in this paper), and provide reliable rankings of eQTLs
in terms of effect sizes instead of p-values alone.
In this paper we propose ACME, a model for the effect size
of cis-acting eQTLs, in which the effects of genotype alleles
on expression are Additive Contributions on the original ex-
pression scale, with Multiplicative Error. In the ACME model
the log of expression is equal to the log of a linear systematic
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term (“log-of-linear”) plus noise and covariate effects: this
seemingly subtle difference from standard log-linear modeling
is of key importance in estimating and interpreting effect sizes.
The ACME model reflects a marked departure from standard
practice in eQTL analyses and has important implications
for downstream inferences on effect sizes and dominance.
Standard normalizations meant to control false positives run
against, as we will argue, the most coherent conception of
eQTL action: namely that gene expression is additive in allele
count. A primary contribution of this paper is to assess the
validity of this conception against the alternatives suggested
by standard practices. Additionally, we provide (i) a fast,
custom fitting algorithm and corresponding software package,
(ii) a robustness analysis of our method, and (iii) diverse
results and comparisons from a full cis-eQTL analysis using
both ACME and existing models.
The organization of the paper is as follows. In the remainder
of this section, we discuss standard eQTL models. In Section
2, we lay out the ACME model and conduct statistical tests on
real data to show its conformity to cis-eQTL action. In Section
3 we analyze robustness of ACME p-values to violations
of model assumptions in real data. Section 4 describes a
simulation study to assess consequences of using standard
normalizations when ACME is the true model. In Section
5 we discuss results from analyses of all cis-eQTLs in nine
tissues (data from the GTEx project, Lonsdale et al. 2013)
using both ACME and existing methods. In Section 6, we
summarize our contributions and discuss future research.
1.1 Existing approaches to gene expression modeling
Gene expression data are rarely analyzed on the original scale,
due to heteroskedasticity and heavy-tailed errors (Ranta-
lainen et al., 2015). Instead, logarithmic transformation of
expression is a standard pre-processing step for many mi-
croarray platforms (e.g. Morley et al., 2004; Irizarry et al.,
2003) and often plays an important role in downstream
analyses such as differential expression (e.g. Network et al.,
2013; Li et al., 2014). RNA-Seq data are inherently count-
based, and statistical analyses of such data often make use
of binomial, negative-binomial, or Poisson generalized linear
models (McCarthy et al., 2012; Zhou et al., 2011; Zwiener
et al., 2014), which use logarithmic or near-logarithmic link
functions. However, count-based modeling is rarely used in
eQTL analysis, due to computational requirements, and the
fact that several stages of read-count normalization are usu-
ally applied to expression data. Furthermore, count-based
modeling may not be necessary in studies with large sample
sizes (Zhou et al., 2011), and eQTL analyses are often per-
formed using linear regression of log-transformed expression,
assuming additive allelic effects on the log scale (e.g. Myers
et al., 2007).
Another common transformation of expression is inverse
quantile-normalization (e.g. Dixon et al., 2007), used to
ensure normality of residuals under the null (Beasley et al.,
2009; Szymczak et al., 2013). Given a vector y of length
n, the quantile-normalization (QN) transformation is the
function Q(yi) = Φ
−1((rank(yi)/(n + 1)), mapping each
value to a normal quantile corresponding to its rank. Hence-
forth, eQTL analysis involving linear regression of quantile-
normalized gene expression will be referred to as “QN-linear”.
For eQTL analyses, the QN-linear model yields p-values that
are approximately uniform under the null of no association
between expression and genotype. However, the quantile-
normalization mapping inherent to this approach erases all
connection between the linear model parameters and the
original gene expression. Hence, estimated coefficients from
QN-linear regression do not reflect the scale of the original
data, and contain almost no information about the true allelic
effect. As a result, QN-linear model effect-size estimates from
eQTLs with clearly diverse signal-to-noise ratios can yield
nearly identical p-values (see Web Appendix ??).
1.2 Notation and data
eQTL data from n samples will be written as follows. The SNP
genotype is the number of minor alleles 0, 1, or 2, rounded
if using imputed data. Genotype is contained in an S × n
matrix where S > 0 is the number of SNP markers; we denote
a (length n) row of the genotype matrix by s. Expression
is measured by the number of mapped reads relative to
the library size (see Web Appendix ??). Read counts for
expression are contained in a T × n matrix where T > 0
is the number of genes or transcripts; the length n row of
expression matrix is denoted c. Finally, the p covariates (e.g.
sex or batch) are stored in a p× n matrix.
The GTEx pilot data set (Ardlie et al., 2015) is used for
all analyses and investigations. Given the purported scope of
the ACME model, the analysis focus is on “cis” gene-SNP
pairs, for which the SNPs are within 1 megabase upstream or
downstream of the transcription start or stop sites. The GTEx
pilot data contains a SNP database and expression data from
nine tissues, each having sample sizes between n = 83 and
n = 156. Each tissue-specific data set had p = 19 covariates:
sex and 3 genotype principal components, which were shared
across all tissues; and 15 PEER (Probabalistic Estimation of
Expression Residuals) factors computed from expression data
(Stegle et al., 2012).
2. The ACME model and diagnostics
This section provides a ground-up introduction of the ACME
model. The first consideration is the appropriate scale of
expression data for error control. As discussed in Section
1.1, errors from linear models of raw gene expression data
are known to be heteroskedastic and non-normal. In Web
Appendix ??, we show that the non-normality observed in
real-data residuals after linear regression with raw expression
causes severe Type-I error discrepancies. Though the QN-
linear model avoids this problem, it is unsuitable for effect-
size estimation (as discussed in Section 1.1). Thus we assess
the commonly-used log transformation, in two ways. First, we
display tests of normality and heteroskedasticity of residuals
after fitting QN-linear, standard linear, and various log-linear
models (see Web Appendix ??) to GTEx data. We see that
models using log-transformed expression perform much better
than those based on raw expression. Comparison to the QN-
linear model results indicate that the log-transformation is
still somewhat subject to noise and outliers. However, we con-
sider the resulting violations of normality and homoskedastic-
ity to be acceptably modest, when balanced against the ability
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to assess effect size with a model that respects the scale of
expression data. (Section 3 provides a deeper look into Type-
I errors from log-based methods.) Second, we assess residual
normality under the box-cox transformation (Box and Cox,
1964), defined for λ ∈ R as
tλ(y) =
{
yλ−1
λ
, λ 6= 0
log(y), λ = 0.
(1)
We perform Shapiro-Wilk tests on box-cox transformed ex-
pression data from null eQTLs (as judged by QN-linear p-
values) subsampled from real data. We find that the log
transformation (λ = 0) consistently results in the fewest
instances of significantly non-normal residuals. These results
are displayed in Web Figure ??.
The analyses described above suggest that the log transfor-
mation puts gene expression on a natural scale for error con-
trol in eQTL effect-size analysis. We now discuss systematic
components of various log-scale effect size models, including
ACME (to be introduced). Henceforth, let yi := log(1 + ci)
denote the log-transformed normalized gene read count from
sample 1 6 i 6 n, where the addition of 1 avoids taking
the logarithm of zero. The value ci is the result of taking
the original raw count for the gene in sample i, library-
normalizing and then scaling up to the magnitude of the
original mean count (see Web Appendix ??). Let si denote
the minor allele count for the SNP in sample i (si ∈ {0, 1, 2}).
Let Zi denote the p × 1 vector of covariates for sample i,
and let γ be an unknown p × 1 covariate coefficient vector.
Finally, let 1, . . . , n be independent N(0, σ
2) errors with
positive variance σ2. Note that the quantities σ and γ may
differ across gene-SNP pairs. It is common in eQTL studies to
assume that the covariate effect ZTi γ contributes to expression
on the same scale as the noise (e.g. Shabalin, 2012). We follow
this practice for all models considered in this paper (including
linear regressions with both raw and quantile-normalized gene
expression). Additional support for this convention can be
seen from the fact that the covariates were computed from
normalized data to reduce the influence of outliers (Ardlie
et al., 2015), so it is natural for them to be residualized on
the log-scale.
2.1 Log-ANCOVA and log-linear models
We now describe two log-scale linear eQTL models. If one
assumes each genotype is associated with a distinct level of
average log-expression, the associated linear model effectively
includes a dominance term for the homozygous genotype
for the reference allele, and yields what we call the “log-
ANCOVA” model:
yi = α010(si) + α111(si) + α212(si) +Z
T
i γ + i. (2)
Here the parameters αj are unknown log-expression means
corresponding to the genotypes, and 1k(si) = 1 if si = k, and
zero otherwise. Another (simpler) log-scale model includes
just one parameter for allele count :
yi = θ0 + θ1si +Z
T
i γ + i. (3)
Above, θ0 is baseline log-expression, and θ1 is the contribution
to log-expression of each reference allele. This model includes
one fewer degree of freedom than log-ANCOVA, due to the
loss of the dominance term α2. Linear regression on allele
count has been heavily used in eQTL analysis (Ardlie et al.,
2015), perhaps partly because evidence of eQTL dominance
effects are scant, even in trans-analyses (Wright et al., 2014).
Furthermore, simpler models like (3) are useful in that they
can be used to test for dominance and, in case of allelic
independence, provide appropriate estimates of eQTL action.
2.2 The ACME Model
Despite the prevalence of the log-linear model (3) in eQTL
analysis, it has not been subjected to careful scrutiny. The
current understanding of cis-eQTL variation in humans is
that it is largely allele-specific (Castel et al., 2015), i.e.,
the transcription of a gene in a particular chromosome is
influenced primarily by one or more SNP alleles on the same
chromosome. Thus, in the absence of feedback mechanisms,
the effect of each SNP allele should be additive on the original
expression scale. To incorporate this understanding while
respecting the heavy-tailed nature of gene expression data, we
propose the following log-scale non-linear regression (ACME):
yi = log(β0 + β1si) +Z
T
i γ + i. (4)
Here β0 is the baseline mean expression, and β1 the addi-
tive contribution of each allele. Exponentiating each side of
equation 4, on the expression scale we have:
ci + 1 =
(
β0 + β1si
) · exp(ZTi γ + i) . (5)
It is clear from this equation that the effect of genotype
is linear in raw expression, as desired. We fit the ACME
model to data via maximum likelihood, using a Gauss-Newton
algorithm, which is derived in Web Appendix ??.
2.2.1 The effect size. The coefficients β1 and β0 from the
ACME model operate on the original expression scale, so they
lend themselves naturally to a “fold-change” interpretation.
In particular, the ratio β1/β0 represents the fraction of mean
increase due to a single referent allele compared to the baseline
genotype 0. We note that Equation (4) may be written
yi = log(β0) + log
(
1 +
β1
β0
si
)
+ZTi γ + i, (6)
which separates the role of β0 in determining baseline ex-
pression and the role of β1/β0 in determining the effect of
genotype. Equation 6 also plays a role in the fitting algorithm.
In what follows we use “effect size” to refer to the ratio β1/β0.
In Web Appendix ?? we obtain a formula for the standard
error of β1/β0, using a reduced Hessian matrix derived from
the model. We note that other notions of effect size may be
of interest to biologists. For example, an alternative effect
size model, studied simultaneously and independently, incor-
porates allele additivity through an explicit focus on a fold-
change parameter (Mohammadi et al., 2016).
2.2.2 Fitting algorithm and software. Though the ACME
model can in principle be fit by brute-force likelihood maxi-
mization, we found stock implementations of this approach to
be slow and unreliable in practice. We have crafted a custom
fitting algorithm for ACME, provided in Web Appendix E.
We have implemented the fitting algorithm, and a parallelized
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wrapper for full cis-genome analysis, in a free and open-source
software package called ACMEeqtl. The package is written
in the R statistical computing language, and is available on
the CRAN repository. In Section 4.1, we benchmark the
computation time of our software.
2.3 Goodness-of-fit tests
In the previous section, we pointed out that the log-
linear model assumes allelic effect additivity on the log-
expression scale, whereas ACME assumes additivity on the
raw-expression scale. These assumptions can be treated as
competing hypotheses, evaluations of which may be per-
formed with goodness-of-fit tests. In this section, we carry
out such tests using data from the GTEx project. To derive
the test, note that the log-linear and ACME models are
each nested within the log-ANCOVA model. For instance,
the log-ANCOVA model reduces to the ACME model via the
parameterization
α0(β) := log(β0),
α1(β) := log(β0) + log
(
1 +
β1
β0
)
,
α2(β) := log(β0) + log
(
1 + 2
β1
β0
)
.
Thus, if either model is sufficient to explain variation in gene
expression, any further improvements in the log-ANCOVA
fit should be small and consistent with the extra degree of
freedom in that model. Conversely, if the fit of log-ANCOVA
is (significantly) better than a smaller model, it suggests the
smaller model is insufficient. In testing sets of coefficients
in nonlinear regression models with normal errors, F -tests
are widely used (Smyth, 2002), and generally better handle
the degree of freedom issues posed by numerous covariates
than do likelihood ratio tests. Define SSE3 as the sum of
squared residuals from the fit of log-ANCOVA, and SSE2 as
the sum of squared residuals from the fit of any nested model
with 2 degrees of freedom (e.g. LL and ACME). Then the
goodness-of-fit test statistic is F = SSE2−SSE3
SSE3/(n−p−3) which is
approximately F -distributed with 1 and n− p− 3 degrees of
freedom. A p-value for the goodness-of-fit test is then obtained
from the upper-tail of F1,n−p−3.
For both the log-linear and ACME models, we applied the
goodness-of-fit F test to every cis-acting gene-SNP pair in
Thyroid tissue (with n = 105 tissue samples) from GTEx
pilot data. As the log-linear and ACME models are indistin-
guishable under the null model (β1 = 0), we examined the
distribution of goodness-of-fit p-values on four bins of cis-
eQTL strength (“Null”, “Weak”, “Medium”, and “Strong”),
as judged by QN-linear model regression p-values (described
fully in Web Appendix ??). To judge the distribution of the
F -test p-values from each model, we plotted Q-Q plots on the
− log10 scale (see Figure 1). On each plot, we also supplied
the genomic inflation factor λ. The genomic inflation factor
is defined by λ := mediani{χ2i }/0.455, where χ2i is the 1
d.f. chi-squared test statistic corresponding to the p-value
for the i-th test, following the original reasoning for genomic
control (Devlin and Roeder, 1999). Figure 1 shows that the
distribution of F -statistic p-values from the log-linear model
grow increasingly non-uniform as eQTLs become more signif-
icant, suggesting that the log-linear model is mis-specified.
In contrast, F -statistic p-values for the ACME model are
approximately uniform for eQTLs of all strengths. In other
words, the fit of the ACME model is largely indistinguishable
from that of log-ANCOVA, whereas the fit of the log-linear
model is largely insufficient to explain non-null eQTLs. Over-
all, these results provide strong empirical support for the raw-
expression allelic additivity assumption of the ACME model,
and against the log-expression additivity of the log-linear
model. We conclude that, among models nested within log-
ANCOVA (which are all models based solely on allelic effect),
ACME best conforms to the underlying eQTL signal. Similar
results were observed after applying the same sub-sampling
and testing pipeline to data from four other GTEx pilot
tissues (see Web Figures ?? and ??). For completeness, we also
applied the above goodness-of-fit pipeline to the QN-linear
model, using the corresponding ANCOVA with quantile-
normalized expression. We find the same upward trend of poor
fits with stronger effect size observed in the LL model. Along
with the discussion in Section 1.1, this further illustrates the
inadequacy of quantile-normalized linear models to capture
eQTL action.
3. Model p-values and Type I error
In this section we address violations of residual normality,
which can affect Type I error. The large number of tests
performed in eQTL analyses presents a special challenge for
false positive control. For cis-analysis, the number of tests is
typically on the order of 107 (Lonsdale et al., 2013). Thus,
using a Bonferroni bound to control family-wise error at 0.05
requires p-values to be accurate at values of 10−9. In order to
perform a test of no effect, i.e., H0 :
β1
β0
= 0 vs. Ha :
β1
β0
6= 0
for a given gene-SNP pair, we fit the ACME model and the
reduced mean-model with β1 = 0, and then derive a p-value
by comparing the resulting F -statistic with the F1,n−p−2
distribution. Non-normality in errors can potentially result
in non-uniform F -statistic p-values under the null. To assess
this, we examined the performance of ACME on simulated
null data with realistic errors. In addition, we examined the
effect of skew in errors for the extremal p-values resulting from
large numbers of tests.
3.1 Empirical performance of the F test
We began our investigation of the empirical performance of
the F test by fitting the ACME model to null data simulated
with realistic residuals. The residuals for each simulated gene-
SNP pair were obtained by re-sampling estimated residuals
from ACME fits to real GTEx data (full details in Web
Appendix ??). Both the ACME and log-linear models were
fit to 1 million null eQTLs generated in this manner, and p-
values were obtained from each method using the F -test. The
results are shown in Figure 2. The F -test p-values appear
nearly uniform for both models, as the inflation factors were
in the range 0.995-1.005 (λ = 1 corresponds to no inflation).
We emphasize that these conclusions address the behavior of
the ACME fit under a realistic null − the earlier analyses
established that ACME offers superior fit for real data when
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evidence of the alternative is strong. Similar results for differ-
ent settings of the variance of the simulated error are shown
in Web Figure ??.
3.2 Importance sampling estimates of Type I error under
skew in residuals
While the results above are encouraging, consideration of 1
million null pairs is not sufficient to assess the quality of very
small p-values under realistic errors. We are unaware of any
attempts via direct data simulation to quantify robustness
in eQTL studies to the stringent multiple testing thresholds
necessary for eQTL studies (as low as 10−9 for cis-testing).
We note that the robustness investigations of Rantalainen
et al. (2015) used only 106 simulations for each investigated
condition.
A computationally efficient way to assess Type-I error rates
for extreme nominal p-values is to perform importance sam-
pling (Tokdar and Kass, 2010), in which samples are drawn
from an appropriate alternative distribution (with β1 6= 0),
then re-weighted to provide an estimated probability of re-
jection under the null. For regression models, skewness in the
error distribution has a major impact on false positive control,
and can cause both conservative or anti-conservative behavior
(Zhou and Wright, 2015). Accordingly, we carried out impor-
tance sampling using the skew-normal model (Azzalini and
Dalla Valle, 1996) for the distribution of , with skewness
determined by a parameter δ, with δ = 0 corresponding to
the assumed normal error model. Simulations were performed
with modest average expression β0 = 100, error variance
σ2 = 1, minor allele frequencies 0.025, 0.05, and 0.1, and
for sample sizes n = 100, 250, and 500. Among the GTEx
datasets used in this paper, most showed skewness in ACME
residuals between -0.5 and 0.5 (see Web Figure ?? for an
example using Adipose GTEx pilot data). We chose the skew-
normal parameter to correspond to skewness in this range
(details in Web Appendix ??). Target type I error values α
ranged from 10−20 to 10−1.
The results for the ACME F -test p-values are shown in
Web Figures ??-??, using the importance sampling approach
detailed in Web Appendix ??. Some general conclusions can
be drawn. For n = 100 and negative skewness in  (with
δ = −0.45), the ACME p-values are noticeably conservative
for α < 10−6. For positive skewness, the p-values are slightly
anti-conservative, but more accurate than for negative skew-
ness due to asymmetry in the behavior of the systematic
component of the ACME model. For larger n = 250, the
conservativeness under negative skewness is less extreme, and
the p-values reasonably accurate to α = 10−9 for the skewness
range shown. This suggests that p-values for the ACME model
should produce acceptable Type-I error rates for most gene-
SNP pairs, even for those with relatively small sample sizes.
Even pairs with higher skew show acceptable type I error
for sample sizes of 250 or greater, and any deviations from
ideal behavior tend to be conservative. These trends hold
across the tested values of the MAF, though the p-value
skew becomes more severe for lower MAF. For trans-analysis,
larger sample sizes may be required due to the more stringent
testing thresholds. However, Wright et al. (2014) suggested
that sample sizes > 1000 are necessary to reliably detect
trans-eQTLs, and for such large studies we would expect
robust ACME p-values, a separate issue from whether ACME
is appropriate for trans-analysis. For small sample sizes and to
serve as an ancillary approach, we describe the MCC method
(Zhou and Wright, 2015) as a fast method to obtain robust
p-values in Web Appendix ??.
4. Power, estimation accuracy, and computation
speed
In this section we present simulation results which display the
detection power, estimation accuracy, and computation speed
of the ACME model versus existing alternatives. Recall the
representation of the ACME model from equation 6, involving
the parameter η := β1/β0. We simulated 100 repetitions of the
model at values of η along the range (−0.5, 10). The sample-
size was set to n = 105, as components of the simulations were
taken from real data (as in Section 3.1). At each repetition,
the other components of the model were set as follows: (1)
allele counts from a randomly sampled real-data allele count
vector corresponding to GTEx samples of Thyroid tissue; (2)
real-data covariate matrix corresponding to Thyroid samples,
constant across all repetitions and values of η; (3) noise
vector (n×1) and covariate effect (γp×1) generated as normals
with mean 0 and covariances σ2 In and σ
2
γIp (respectively),
independent within and across repetitions.
We replicated the above simulation framework for various
choices of σγ , with σ fixed at 1. We then applied linear
(RAW), quantile-normalized linear (QN), log-linear (LL), log-
ANCOVA (ANCOVA), and ACME models to each instance of
the simulation. For each value of η, we computed the average
and standard deviation over the repetitions of the follow-
ing metrics (per model). (1) F -test p-value for hypotheses
H0 : η = 0 vs. H1 : η 6= 0; (2) Estimated raw expression
value when reference allele count equals 1; (3) Estimated raw
expression value when reference allele count equals 2. Note
that estimation with the QN model cannot provide (2) or
(3), as the model is based on a rank-normalized expression.
Furthermore, parameters of the LL model are not directly
comparable to those of ACME or RAW (as they are additive
on the log-expression scale), which motivates our choice to
evaluate estimated expression rather than estimated β1.
In Figure 3, we display results from the above simulation
framework with σ = σγ = 1. Note that, for the top plot,
the x-axis is transformed according to w(η) := log(1 + 2η),
a scale which better displays the results when η ∈ (−0.5, 0).
We replicated the simulation framework with other choices
of σγ both above and below σ. The results of these repli-
cations are shown in Web Figure ??. Our results show that
the ACME model achieves the most power and estimation
accuracy among the alternative methods. Hence, if the ACME
model is the best representation of underlying eQTL biology
in terms of allele count (as the analyses in Section 2.3 suggest),
use of the existing methods reduces accuracy and sensitivity.
Additionally, in Web Figure ??, we show that when σγ is
increased (i.e., the covariates have more effect), the accuracy
and sensitivity of the competing methods is even further
reduced.
Remark: The power of log-ANCOVA is quite close to that
of ACME. This is expected, as log-ANCOVA contains ACME,
the true simulated model. Thus, in this simulation study, the
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log-ANCOVA results act mainly as a reference; the larger
model’s practical and conceptual shortcomings compared to
ACME were discussed in Section 2. The focus of this study is
mainly on single-parameter models and the consequences of
misspecification.
4.1 Computation times
To assess computation speed, we timed various methods on
every simulation instance for Figure 3. There were 10,000
unique values of η, and therefore 1 million simulation in-
stances. On each instance, we recorded the computation time
for: (1) the LL model with least-squares estimation; (2) the
ACME model with maximum likelihood using the BFGS
method implemented in optim from R; (3) the ACME model
with the custom fitting algorithm derived in Web Appendix
??. The timing of (1) will be of the same order as any other
procedure based on least-squares (RAW, QN, and ANCOVA).
The timing of procedure (2) is provided as a benchmark for
procedure (3). All computations were performed on an Intel
Xeon E5-2640 (2.50 GHz), using the R, and timed with the
microbenchmark package.
The mean and standard deviation of computation times for
the procedures, over the 1 million simulation instances, were
as follows: least-squares at 0.129ms (0.233), BFGS at 2.687ms
(1.270), custom ACME at 0.470ms (0.285). So, the efficiency
of the custom ACME algorithm is quite comparable to that
of least-squares estimating equations, and outstrips stock
optimization methods. The complete package implementing
our algorithm, including wrappers that employ parallelization
to process all cis-eQTL results from massive-scale eQTL data,
is available in the ACMEeqtl package on the CRAN respository.
5. Large-scale real data analysis
This section contains further comparisons between different
effect-size models. Note that the most important real-data
comparisons between ACME and standard models are the
goodness-of-fit tests shown in Section 2.3. Those tests showed
that ACME best fits cis-eQTL data, compared to other allele-
count models. Moreover, ACME estimates correspond to a
coherent biological interpretation of cis-eQTL action. In light
of this, it can be asked whether effect-size rankings from other
methods, at least, correspond to those from ACME. Effect
size estimates for all cis-pairs were computed from Thyroid
tissue data using the QN-linear, LL, and ACME models. The
top plots in Figure 4 show that effect-size ordering given to
the strongest eQTLs by QN and LL differ markedly from
ACME. Also in Figure 4 is a plot of ACME versus QN-
linear regression p-values, shown mainly to provide a fuller
comparison to Ardlie et al. (2015) and other studies which rely
on the QN-linear model. It is clear that, while QN p-values are
associated with ACME’s (as one would hope), they are by no
means identical in rank, and quite different in magnitude for
the strongest eQTLs. Furthermore, as shown in the top row of
plots, many QN effect sizes differed in sign from ACME’s. All
these comparisons held across tissues, as shown in Web Figure
??. Beyond method comparisons, we also display summaries
of ACME effect sizes in Web Figure ??. Computation times
for real-data analyses were recorded for both the ACME and
QN model fitting procedures, using the same PC as mentioned
in Section 4.1. The R packages MatrixEQTL and ACMEeqtl pro-
vide full-tissue cis-eQTL procedures for the QN and ACME
models (respectively). We timed the run of each procedure
on each of the nine tissues. The results are shown in the
bottom-right of Figure 4. We note that the ACME software
benefits from parallelization that the Matrix-EQTL software
currently does not employ. This explains why the ACME full-
tissue procedure is faster than Matrix-EQTL, even though the
former is based on an iterative optimization procedure.
6. Discussion
We have proposed ACME, a new model for the effect-size of
cis-eQTLs. ACME follows a simple additive model for cis-
eQTL action, and is supported by careful analysis of real
data. In particular, we show via goodness-of-fit tests that
while the error distribution of gene expression is best mod-
eled on the log-scale, cis-eQTL additive allelic effects occur
on the original scale, contrary to assumptions implied by
standard transformations. Beyond simply harmonizing some
biological considerations regarding allele-specific expression,
this analysis shows that a single parameter can be used in
most instances to catalog the effect size of a cis-eQTL, and
that dominance in cis-eQTLs appears to be rare. Simulations
in Sections 3 and 4 showed the robustness and the superior
power of the ACME model. Real-data analyses in Section 5
suggested that, for eQTL ranking purposes, estimates and p-
values from standard models (QN and LL) are not adequate
stand-ins for those from ACME. Furthermore, as seen in the
goodness-of-fit tests, use of the QN-linear or LL models can
create false evidence of dominance. Finally, we showed ACME
estimation on all cis-pairs is computationally feasible, and
have provided open-source software.
We believe the ACME model places cis-eQTL effect size
analysis on a solid statistical foundation, and can be readily
implemented in current eQTL studies. The results may be
useful for investigations in which interpretable eQTL effect
sizes and reliable rankings are relevant, such as examining
enrichment and overlap with genome-wide association studies
(Zhu et al., 2016). Furthermore, our analytic standard errors
for ACME effect sizes allows ACME estimates to be used
directly in methods for downstream analysis of multi-tissue
eQTL variation (Flutre et al., 2013; Li et al., 2013).
Though we did not explore the application of the ACME
model to trans-eQTL analysis, the ACME model can in prin-
ciple be applied to trans-eQTLs. However, for trans-eQTLs,
dominance effects may be more plausible, while current sam-
ple sizes may be inadequate to fully investigate such effects.
Thus we consider the use of the ACME model for trans-eQTLs
to be exploratory. Another possible extension is a multi-SNP
ACME model. However, it is not obvious that allelic additivity
should hold in a multi-SNP model. Nonetheless, to facilitate
analysis, we have implemented a step-wise fitting algorithm
for a multi-SNP ACME model using additivity across loci,
with code included in our software package. These estimates
can be used to consider preliminary ACME models that are
additive in genotypes across SNPs, pending more rigorous
development of a multi-SNP approach.
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Supplementary Materials
Web Appendices and Web Figures referenced in Sections 1.1,
1.2, 2, 2.1, 2.2, 2.3, 3.1, 3.2, 4, 4.1, and 5 are available with
this paper at the Biometrics website on Wiley Online Library.
Code to fit the ACME model comes with the ACMEeqtl
package, available on the CRAN repository.
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Figure 1: Q-Q plots of likelihood ratio test p-values for
ACME, LL, and QN models, in each sector of GTEx Thyroid
sample data, n = 105. The grey line is where we would
expect the p-values (represented by the red dots) to fall if they
were perfectly uniform, and the green line represents the 95%
window of error around this expectation. λ is the estimated
genomic inflation factor.
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Figure 2: p-value distributions from null simulated data with
realistic errors and real covariate/genotype data. λ values are
inflation factors.
Figure 3: Results of large-scale simulation experiment. Mid-
dle: − log 10 F -test p-values as a function of η. Left and right:
predicted raw expression with one and two reference alleles,
respectively.
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Figure 4: Results of genome-wide cis-eQTL ACME effect
size estimations on Thyroid tissue (n = 105) from GTEx data.
Top row: comparisons of ACME effect sizes (transformed with
w as introduced in Section 4) with both QN and LL effect
sizes. Bottom-left: QN vs ACME regression p-values. Bottom-
right: Full-tissue procedure times of the Matrix-EQTL and
ACME fitting softwares.
